Provided by Tiger Trade Technology Pte. Ltd.

Actinium Pharmaceuticals

1.14
-0.0112-0.97%
Volume:55.75K
Turnover:64.13K
Market Cap:35.53M
PE:-1.03
High:1.17
Open:1.17
Low:1.13
Close:1.15
52wk High:2.41
52wk Low:1.03
Shares:31.20M
Float Shares:31.04M
Volume Ratio:0.67
T/O Rate:0.18%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.1090
EPS(LYR):-1.2718
ROE:-133.09%
ROA:-33.76%
PB:2.58
PE(LYR):-0.90

Loading ...

Nov 26, 2025

Major Issues Report

Form 8-K - Current report
Nov 14, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 08, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 09, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 09, 2025

Major Issues Report

Form 8-K - Current report
Apr 01, 2025

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Nov 28, 2024

Major Issues Report

Form 8-K - Current report
Nov 14, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 08, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Nov 05, 2024

Major Issues Report

Form 8-K - Current report
Aug 05, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 05, 2024

Major Issues Report

Form 8-K - Current report
Apr 26, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Mar 29, 2024

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Mar 29, 2024

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 09, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Feb 03, 2024

Correspondence

Form CORRESP - Correspondence
Dec 01, 2023

Major Issues Report

Form 8-K - Current report
Nov 02, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 14, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]